We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dynavax's HEPLISAV Shows Increased Protection Rate for Chronic Kidney Disease Patients

News   Oct 30, 2009

 
Dynavax's HEPLISAV Shows Increased Protection Rate for Chronic Kidney Disease Patients
 
 
 

RELATED ARTICLES

Autism Linked to Egg Cells' Difficulty Creating Large Proteins

News

Genetic factors underlying fragile X syndrome, and potentially from other autism-related disorders, stem from defects in the cell's ability to create unusually large protein structures

READ MORE

An Easier Way to Separate Glycopeptides

News

Chinese researchers have developed interfacially polymerized porous polymer particles for low- abundance glycopeptide separation. These polymer particles - with hydrophilic-hydrophobic heterostructured nanopores - can separate low-abundance glycopeptides from complex biological samples with high-abundance background molecules efficiently.

READ MORE

Zika Vaccine Clinical Trial Begins

News

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE